Jenal & Partners Biosafety Consulting was registered in 2001 in Switzerland.
We support you with achieving your business goals and maintaining business continuity by integrating the latest developments in science and technology as well as by adopting internationally accepted standards in risk management, safety and security.
Languages used in the company are English, German and French
JENAL & PARTNERS
Phone +41 61 723 28 58
Fax +41 61 723 28 59
Mobile +41 79 652 92 17
Partners: Ursula Jenal
, Philippe Stroot
Collaborators: Patrick King
Mobile +32 484 274 365
Philippe Stroot holds a PhD in biological sciences of the University of Namur, Belgium. After 7 years of academic research at the University of Namur and one year as scientific expert for the Belgian federal administration, he joined GlaxoSmithKline Biologicals (SmithKline Beecham Biologicals at that time) in 1990 as International Vaccine Training Manager.
Appointed Biosafety Officer for the company, Philippe Stroot established and managed the biosafety programme in R&D, Manufacturing and Quality Control from 1993 to 1997. During those years, he worked on harmonising biosafety, radioprotection and waste management practices, realised the first legal registration of the company's biological activities and established their biocontainment design specifications.
In 1997, he was hired as R&D Operations Manager during the construction of GSK Biologicals' main research building. During 8 years, he managed the existing R&D facilities, including more than 10000 m2 of biocontainment laboratories, and acted as the users' representative for the on-going construction projects. He was also in charge of co-ordinating health and safety programmes in R&D.
He then joined GSK Biologicals Corporate EHS team as Global Biosafety Manager. In this position, that he held until the end of 2006, he was in charge of implementing and co-ordinating the Biosafety programme of GSK Biologicals worldwide.
During that period, Philippe Stroot started to work as an independent biosafety expert. He joined Jenal & Partners in 2005.
Philippe Stroot has been a member of the American Biological Safety Association (ABSA) since 1993 and was a founder member of the European BioSafety Association (EBSA) in 1996. He participated to a number of international working groups including the CEN Technical Committee on Biotechnology (TC233) and has recently been representing Jenal & Partners in the CEN Workshop set up to develop a new international biorisk management standard (WS31).
In 2007 Philippe Stroot launched his own Biosafety consulting company, Xibios, located in Belgium.